REPORT ID 5369

Global Chronic Idiopathic Constipation (CIC) Drugs Market Research Report 2017

Publish Date
21-Dec-17
Pages
118
Format
Electronic (PDF)

In this report, the global Chronic Idiopathic Constipation (CIC) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Chronic Idiopathic Constipation (CIC) Drugs in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Chronic Idiopathic Constipation (CIC) Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Actavis
    Chugai Pharmaceutical
    Ferring International Center S.A.
    Synergy Pharmaceuticals
    Pfizer
    GlaxoSmithKline
    Roche Holding AG
    Sanofi
    Bayer AG
    Salix Pharmaceuticals Ltd
    Sucampo Pharmaceuticals Inc
    Ironwood Pharmaceuticals
    Progenics Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Lubiprostone
    Linaclotide
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospitals & Clinics
    Ambulatory Surgical Centres
    Long Term Care Centres
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Chronic Idiopathic Constipation (CIC) Drugs Market Research Report 2017
1 Chronic Idiopathic Constipation (CIC) Drugs Market Overview
    1.1 Product Overview and Scope of Chronic Idiopathic Constipation (CIC) Drugs
    1.2 Chronic Idiopathic Constipation (CIC) Drugs Segment by Type (Product Category)
        1.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Production Market Share by Type (Product Category) in 2016
        1.2.3 Lubiprostone
        1.2.4 Linaclotide
        1.2.5 Others
    1.3 Global Chronic Idiopathic Constipation (CIC) Drugs Segment by Application
        1.3.1 Chronic Idiopathic Constipation (CIC) Drugs Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Hospitals & Clinics
        1.3.3 Ambulatory Surgical Centres
        1.3.4 Long Term Care Centres
        1.3.5 Others
    1.4 Global Chronic Idiopathic Constipation (CIC) Drugs Market by Region (2012-2022)
        1.4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Chronic Idiopathic Constipation (CIC) Drugs (2012-2022)
        1.5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Status and Outlook (2012-2022)
        1.5.2 Global Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Chronic Idiopathic Constipation (CIC) Drugs Market Competition by Manufacturers
    2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Production and Share by Manufacturers (2012-2017)
    2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Chronic Idiopathic Constipation (CIC) Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Chronic Idiopathic Constipation (CIC) Drugs Market Competitive Situation and Trends
        2.5.1 Chronic Idiopathic Constipation (CIC) Drugs Market Concentration Rate
        2.5.2 Chronic Idiopathic Constipation (CIC) Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Capacity and Market Share by Region (2012-2017)
    3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Production and Market Share by Region (2012-2017)
    3.3 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Chronic Idiopathic Constipation (CIC) Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption by Region (2012-2017)
    4.2 North America Chronic Idiopathic Constipation (CIC) Drugs Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Production, Consumption, Export, Import (2012-2017)
    4.4 China Chronic Idiopathic Constipation (CIC) Drugs Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Chronic Idiopathic Constipation (CIC) Drugs Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Production, Consumption, Export, Import (2012-2017)
    4.7 India Chronic Idiopathic Constipation (CIC) Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Chronic Idiopathic Constipation (CIC) Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Production and Market Share by Type (2012-2017)
    5.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue and Market Share by Type (2012-2017)
    5.3 Global Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2012-2017)
    5.4 Global Chronic Idiopathic Constipation (CIC) Drugs Production Growth by Type (2012-2017)

6 Global Chronic Idiopathic Constipation (CIC) Drugs Market Analysis by Application
    6.1 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption and Market Share by Application (2012-2017)
    6.2 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Profiles/Analysis
    7.1 Actavis
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Chronic Idiopathic Constipation (CIC) Drugs Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Actavis Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Chugai Pharmaceutical
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Chronic Idiopathic Constipation (CIC) Drugs Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Ferring International Center S.A.
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Chronic Idiopathic Constipation (CIC) Drugs Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Ferring International Center S.A. Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Synergy Pharmaceuticals
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Chronic Idiopathic Constipation (CIC) Drugs Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Pfizer
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Chronic Idiopathic Constipation (CIC) Drugs Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 GlaxoSmithKline
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Chronic Idiopathic Constipation (CIC) Drugs Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Roche Holding AG
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Chronic Idiopathic Constipation (CIC) Drugs Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Roche Holding AG Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Sanofi
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Chronic Idiopathic Constipation (CIC) Drugs Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Bayer AG
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Chronic Idiopathic Constipation (CIC) Drugs Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Bayer AG Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Salix Pharmaceuticals Ltd
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Chronic Idiopathic Constipation (CIC) Drugs Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Sucampo Pharmaceuticals Inc
    7.12 Ironwood Pharmaceuticals
    7.13 Progenics Pharmaceuticals

8 Chronic Idiopathic Constipation (CIC) Drugs Manufacturing Cost Analysis
    8.1 Chronic Idiopathic Constipation (CIC) Drugs Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Chronic Idiopathic Constipation (CIC) Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Chronic Idiopathic Constipation (CIC) Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Chronic Idiopathic Constipation (CIC) Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Chronic Idiopathic Constipation (CIC) Drugs Market Forecast (2017-2022)
    12.1 Global Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Chronic Idiopathic Constipation (CIC) Drugs Price and Trend Forecast (2017-2022)
    12.2 Global Chronic Idiopathic Constipation (CIC) Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Chronic Idiopathic Constipation (CIC) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Chronic Idiopathic Constipation (CIC) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Chronic Idiopathic Constipation (CIC) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Chronic Idiopathic Constipation (CIC) Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Chronic Idiopathic Constipation (CIC) Drugs Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer